AbbVie today announced that its Phase 3 TEMPO-2 study with

This $ABBV stock news is available only to Bulios Black members.

Upgrade

ABBV

$212.32

AbbVie

-0.67%

What are they talking about

These stocks were most talked about on Bulios today

AMZN

Amazon

$265.01

+1.91%

GOOG

Alphabet

$384.90

-0.04%

MSFT

Microsoft

$421.06

+1.66%

NVDA

Nvidia

$223.47

+0.17%

TSLA

Tesla

$417.26

+2.36%

Fair Price Index

List of the largest and most watched stocks from around the world, including their fair prices based on DCF and Relative valuation.

Stock

Result/Price

Fair Price

ASML

Downside

$1,550.13

$4,818.83

87.53%

CVX

Chevron

Downside

$191.36

$889.73

1.12%

DIS

Disney

Downside

$104.08

$106.82

0.17%

JPM

JPMorgan

Upside

$301.97

$065.08

64.25%

NVDA

Nvidia

Downside

$223.47

$915.20

42.00%